Ekso Bionics Holdings Inc [NASDAQ: EKSO] surged by $0.04 during the normal trading session on while it closed the day at $0.77.
Ekso Bionics Holdings Inc stock has also gained 18.57% of its value over the past 7 days. However, EKSO stock has declined by -26.01% in the 3 months of the year. Over the past six months meanwhile, it has lost -30.05% and gained 26.15% year-on date.
The market cap for EKSO stock reached $19.85 million, with 22.00 million shares outstanding and 21.09 million shares in the current float. Compared to the average trading volume of 161.42K shares, EKSO reached a trading volume of 39837916 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Ekso Bionics Holdings Inc [EKSO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EKSO shares is $5.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EKSO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
SunTrust have made an estimate for Ekso Bionics Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 14, 2016.
The Average True Range (ATR) for Ekso Bionics Holdings Inc is set at 0.09, with the Price to Sales ratio for EKSO stock in the period of the last 12 months amounting to 1.12. The Price to Book ratio for the last quarter was 1.14, with the Price to Cash per share for the same quarter was set at 0.32.
EKSO stock trade performance evaluation
Ekso Bionics Holdings Inc [EKSO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 18.57. With this latest performance, EKSO shares gained by 10.09% in over the last four-week period, additionally sinking by -30.05% over the last 6 months – not to mention a drop of -69.22% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EKSO stock in for the last two-week period is set at 60.44, with the RSI for the last a single of trading hit 68.73, and the three-weeks RSI is set at 54.72 for Ekso Bionics Holdings Inc [EKSO]. The present Moving Average for the last 50 days of trading for this stock 0.7391, while it was recorded at 0.6684 for the last single week of trading, and 1.0697 for the last 200 days.
Ekso Bionics Holdings Inc [EKSO]: An insightful look at the core fundamentals
Ekso Bionics Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.14 and a Current Ratio set at 2.81.
Ekso Bionics Holdings Inc [EKSO]: Institutional Ownership
There are presently around $25.25%, or 27.42%% of EKSO stock, in the hands of institutional investors. The top three institutional holders of EKSO stocks are: KENT LAKE CAPITAL LLC with ownership of 0.7 million shares, which is approximately 3.9959%. VANGUARD GROUP INC, holding 0.59 million shares of the stock with an approximate value of $$0.63 million in EKSO stocks shares; and VANGUARD GROUP INC, currently with $$0.32 million in EKSO stock with ownership which is approximately 1.7223%.
